See more : Suzhou TZTEK Technology Co., Ltd (688003.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Daiken Medical Co., Ltd. (7775.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Daiken Medical Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Raja Ferry Port Public Company Limited (RP.BK) Income Statement Analysis – Financial Results
- Sinofert Holdings Limited (SNFRY) Income Statement Analysis – Financial Results
- Tenneco Inc. (0RT7.L) Income Statement Analysis – Financial Results
- Swarmio Media Holdings Inc. (SWMIF) Income Statement Analysis – Financial Results
- Rottneros AB (publ) (RROS.ST) Income Statement Analysis – Financial Results
Daiken Medical Co., Ltd. (7775.T)
About Daiken Medical Co., Ltd.
Daiken Medical Co., Ltd. manufactures and distributes medical devices and equipment in Japan and internationally. The company offers syringe pumps, disposable infusion pumps, portable disposable infusers, endobronchial blocker tubes, suction containers, connecting tubes, suction tips, medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. It also trades in medical equipment. The company sells its products under the COOPDECH brand. Daiken Medical Co., Ltd. was incorporated in 1968 and is headquartered in Izumi, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.75B | 9.14B | 8.54B | 7.86B | 8.52B | 8.41B | 8.59B | 8.40B | 8.26B | 8.03B | 7.64B | 7.07B | 6.52B | 6.24B | 5.74B | 5.18B | 4.61B |
| Cost of Revenue | 5.77B | 5.61B | 4.86B | 4.50B | 4.79B | 4.47B | 4.36B | 3.99B | 3.94B | 3.86B | 3.71B | 3.56B | 3.35B | 3.27B | 2.93B | 2.65B | 2.34B |
| Gross Profit | 3.98B | 3.53B | 3.68B | 3.36B | 3.73B | 3.94B | 4.23B | 4.41B | 4.32B | 4.17B | 3.92B | 3.51B | 3.16B | 2.97B | 2.81B | 2.54B | 2.27B |
| Gross Profit Ratio | 40.84% | 38.64% | 43.14% | 42.73% | 43.81% | 46.84% | 49.22% | 52.48% | 52.25% | 51.94% | 51.39% | 49.60% | 48.51% | 47.61% | 49.00% | 48.93% | 49.31% |
| Research & Development | 249.00M | 316.00M | 382.00M | 448.00M | 488.00M | 512.00M | 532.93M | 479.77M | 447.61M | 437.00M | 434.00M | 311.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.90B | 1.79B | 135.00M | 133.00M | 148.00M | 196.00M | 233.00M | 253.00M | 276.00M | 269.00M | 265.00M | 248.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 340.00M | 316.00M | 306.00M | 269.00M | 266.00M | 1.93B | 1.90B | 1.94B | 1.87B | 1.82B | 190.00M | 307.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.24B | 2.11B | 2.09B | 1.94B | 2.02B | 2.13B | 2.14B | 2.19B | 2.15B | 2.09B | 2.07B | 1.90B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 2.67M | 4.07M | 39.82M | 20.25M | 1.02M | 1.67M | 6.48M | 13.69M | 6.82M | 14.43M | -1.19M | 13.17M | -8.44M | 3.16M | -39.46M | -3.22M |
| Operating Expenses | 2.54B | 2.48B | 2.53B | 2.44B | 2.54B | 2.69B | 2.72B | 2.70B | 2.62B | 2.55B | 2.53B | 2.24B | 2.15B | 2.00B | 1.98B | 1.83B | 1.74B |
| Cost & Expenses | 8.31B | 8.08B | 7.39B | 6.94B | 7.33B | 7.16B | 7.08B | 6.69B | 6.57B | 6.41B | 6.25B | 5.81B | 5.50B | 5.27B | 4.90B | 4.47B | 4.08B |
| Interest Income | 0.00 | 3.00M | 3.00M | 3.00M | 4.00M | 21.00K | 129.00K | 130.00K | 416.00K | 595.00K | 609.00K | 417.00K | 350.00K | 425.00K | 622.00K | 1.06M | 1.29M |
| Interest Expense | 4.83M | 3.97M | 3.74M | 3.81M | 4.55M | 4.76M | 4.36M | 3.94M | 6.14M | 4.24M | 6.20M | 10.05M | 13.59M | 14.74M | 20.07M | 33.09M | 32.11M |
| Depreciation & Amortization | 214.28M | 268.86M | 315.96M | 233.09M | 254.73M | 304.98M | 250.98M | 187.54M | 183.57M | 155.36M | 188.96M | 250.28M | 302.34M | 303.22M | 241.80M | 174.09M | 161.06M |
| EBITDA | 1.66B | 1.30B | 1.47B | 1.18B | 1.45B | 1.46B | 1.62B | 1.89B | 1.90B | 1.77B | 1.58B | 1.51B | 1.32B | 1.24B | 1.07B | 828.59M | 687.83M |
| EBITDA Ratio | 17.00% | 14.50% | 17.22% | 15.49% | 17.22% | 18.48% | 20.50% | 22.55% | 22.92% | 22.20% | 20.87% | 21.37% | 20.42% | 20.34% | 18.84% | 16.27% | 14.93% |
| Operating Income | 1.44B | 1.05B | 1.15B | 921.22M | 1.19B | 1.25B | 1.51B | 1.71B | 1.70B | 1.62B | 1.39B | 1.26B | 1.01B | 974.35M | 835.43M | 707.34M | 528.70M |
| Operating Income Ratio | 14.80% | 11.54% | 13.48% | 11.72% | 14.01% | 14.86% | 17.54% | 20.37% | 20.53% | 20.19% | 18.20% | 17.84% | 15.57% | 15.61% | 14.56% | 13.65% | 11.47% |
| Total Other Income/Expenses | -6.18M | -29.43M | 459.00K | 23.53M | -3.30M | -95.92M | -143.28M | -13.64M | 7.27M | -20.76M | -6.94M | -8.43M | -12.34M | -59.06M | -35.00M | -85.93M | -36.78M |
| Income Before Tax | 1.44B | 1.03B | 1.15B | 944.75M | 1.19B | 1.15B | 1.36B | 1.70B | 1.70B | 1.60B | 1.38B | 1.25B | 1.00B | 915.29M | 800.43M | 621.41M | 491.92M |
| Income Before Tax Ratio | 14.73% | 11.22% | 13.48% | 12.02% | 13.97% | 13.72% | 15.87% | 20.21% | 20.62% | 19.93% | 18.11% | 17.72% | 15.38% | 14.66% | 13.95% | 11.99% | 10.67% |
| Income Tax Expense | 447.86M | 312.96M | 320.28M | 269.52M | 331.56M | 302.07M | 350.34M | 451.61M | 549.93M | 503.21M | 501.46M | 464.79M | 598.13M | 360.23M | 312.92M | 251.92M | 174.54M |
| Net Income | 988.60M | 712.06M | 831.06M | 675.23M | 859.55M | 851.60M | 1.01B | 1.25B | 1.15B | 1.10B | 881.50M | 787.54M | 404.11M | 555.06M | 487.50M | 369.49M | 317.37M |
| Net Income Ratio | 10.14% | 7.79% | 9.73% | 8.59% | 10.08% | 10.13% | 11.79% | 14.83% | 13.96% | 13.67% | 11.54% | 11.14% | 6.20% | 8.89% | 8.49% | 7.13% | 6.89% |
| EPS | 34.41 | 24.79 | 28.93 | 23.50 | 29.92 | 29.05 | 33.79 | 41.55 | 38.45 | 36.36 | 29.19 | 26.53 | 13.68 | 18.93 | 16.77 | 32.15 | 14.29 |
| EPS Diluted | 34.41 | 24.79 | 28.93 | 23.50 | 29.92 | 29.05 | 33.76 | 41.50 | 38.41 | 36.29 | 29.00 | 26.17 | 13.50 | 18.60 | 16.35 | 31.37 | 14.29 |
| Weighted Avg Shares Out | 28.73M | 28.73M | 28.73M | 28.73M | 28.73M | 29.31M | 29.95M | 29.99M | 29.99M | 30.19M | 30.20M | 29.69M | 29.54M | 29.33M | 29.07M | 11.49M | 22.22M |
| Weighted Avg Shares Out (Dil) | 28.73M | 28.73M | 28.73M | 28.73M | 28.73M | 29.31M | 29.98M | 30.02M | 30.03M | 30.25M | 30.40M | 30.10M | 29.93M | 29.85M | 29.81M | 11.49M | 22.22M |
Source: https://incomestatements.info
Category: Stock Reports